KHIRON LIFE SCIENCES CORP (KHRN.CA) Stock Price & Overview
TSX-V:KHRN • CA49374L3065
Current stock price
The current stock price of KHRN.CA is 0.04 CAD. Today KHRN.CA is down by 0%. In the past month the price decreased by -11.11%. In the past year, price decreased by -75%.
KHRN.CA Key Statistics
- Market Cap
- 7.188M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.17
- Dividend Yield
- N/A
KHRN.CA Stock Performance
KHRN.CA Stock Chart
KHRN.CA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to KHRN.CA. When comparing the yearly performance of all stocks, KHRN.CA is a bad performer in the overall market: 98.86% of all stocks are doing better.
KHRN.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to KHRN.CA. KHRN.CA may be in some trouble as it scores bad on both profitability and health.
KHRN.CA Earnings
KHRN.CA Forecast & Estimates
7 analysts have analysed KHRN.CA and the average price target is 0.1 CAD. This implies a price increase of 155% is expected in the next year compared to the current price of 0.04.
For the next year, analysts expect an EPS growth of 39.13% and a revenue growth 36.43% for KHRN.CA
KHRN.CA Groups
Sector & Classification
KHRN.CA Financial Highlights
Over the last trailing twelve months KHRN.CA reported a non-GAAP Earnings per Share(EPS) of -0.17. The EPS decreased by -59.04% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.05 |
KHRN.CA Ownership
KHRN.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.15 | 2.601B | ||
| CRON | CRONOS GROUP INC | 39.86 | 1.315B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.026B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 5.45 | 945.072M | ||
| GUD | KNIGHT THERAPEUTICS INC | 141.95 | 668.565M | ||
| WEED | CANOPY GROWTH CORP | N/A | 541.521M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 20.05 | 418.637M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 414.781M | ||
| TSND | TERRASCEND CORP | N/A | 357.139M | ||
| HITI | HIGH TIDE INC | 10.06 | 272.49M | ||
| ACB | AURORA CANNABIS INC | 56.81 | 259.732M | ||
| OGI | ORGANIGRAM GLOBAL INC | 27.43 | 254.956M | ||
| XLY | AUXLY CANNABIS GROUP INC | 13.86 | 177.715M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find more growth stocks the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About KHRN.CA
Company Profile
Khiron Life Sciences Corp. is a vertically integrated medical and consumer packaged goods (CPG) cannabis company with core operations in Latin America and operational activities in Europe and North America. The company is headquartered in Toronto, Ontario and currently employs 310 full-time employees. The company went IPO on 2012-10-25. The Company’s product lines include medical cannabis products, health services and wellbeing products. The medical cannabis product sells branded medical cannabis products. The health service operates its own network of medium complexity health centers (operating under the ILANS and Zerenia brands) and Zerenia satellite clinics offering a range of health, medical and surgical services in alignment with insurance company partners. Its wellbeing product is focused on delivering the benefits of cannabidiol (CBD) a range of various branded consumer packaged goods, such as its Kuida cosmetics line. The firm provides patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure. The firm sells its products in Colombia, Peru, Germany, United Kingdom and Brazil.
Company Info
IPO: 2012-10-25
KHIRON LIFE SCIENCES CORP
100 King St.W., Suite 1600, 1 First Canadian Place
TORONTO ONTARIO V6C 2B5 CA
CEO: Alvaro Torres
Employees: 310
Phone: 17055273564.0
KHIRON LIFE SCIENCES CORP / KHRN.CA FAQ
What does KHIRON LIFE SCIENCES CORP do?
Khiron Life Sciences Corp. is a vertically integrated medical and consumer packaged goods (CPG) cannabis company with core operations in Latin America and operational activities in Europe and North America. The company is headquartered in Toronto, Ontario and currently employs 310 full-time employees. The company went IPO on 2012-10-25. The Company’s product lines include medical cannabis products, health services and wellbeing products. The medical cannabis product sells branded medical cannabis products. The health service operates its own network of medium complexity health centers (operating under the ILANS and Zerenia brands) and Zerenia satellite clinics offering a range of health, medical and surgical services in alignment with insurance company partners. Its wellbeing product is focused on delivering the benefits of cannabidiol (CBD) a range of various branded consumer packaged goods, such as its Kuida cosmetics line. The firm provides patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure. The firm sells its products in Colombia, Peru, Germany, United Kingdom and Brazil.
Can you provide the latest stock price for KHIRON LIFE SCIENCES CORP?
The current stock price of KHRN.CA is 0.04 CAD.
What is the dividend status of KHIRON LIFE SCIENCES CORP?
KHRN.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of KHRN stock?
KHRN.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the valuation of KHIRON LIFE SCIENCES CORP (KHRN.CA) based on its PE ratio?
KHIRON LIFE SCIENCES CORP (KHRN.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.17).
What is the expected growth for KHRN stock?
The Revenue of KHIRON LIFE SCIENCES CORP (KHRN.CA) is expected to grow by 36.43% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of KHRN stock?
KHIRON LIFE SCIENCES CORP (KHRN.CA) has a market capitalization of 7.19M CAD. This makes KHRN.CA a Nano Cap stock.